Shanghai Universal Biotech Co.,Ltd. (SHE:301166)
China · Delayed Price · Currency is CNY 30.46
-0.23 (-0.75%)
Apr 21, 2026, 4:00 PM EDT
SHE:301166 Market Cap
SHE:301166 has a market cap or net worth of 2.61 billion as of April 21, 2026. Its market cap has increased by 3.14% in one year.
Market Cap
2.61B
Enterprise Value
1.35B
Revenue
1.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
30.46
Market Cap Chart
Since December 28, 2021, SHE:301166's market cap has decreased from 9.10B to 2.61B, a decrease of -71.31%. That is a compound annual growth rate of -25.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 2.61B | 2.63% |
| Dec 31, 2025 | 2.54B | 3.97% |
| Dec 31, 2024 | 2.45B | -26.49% |
| Dec 29, 2023 | 3.33B | -15.99% |
| Dec 30, 2022 | 3.96B | -55.60% |
| Dec 31, 2021 | 8.93B | -1.94% |
| Dec 28, 2021 | 9.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Sihuan Bioengineering | 3.12B |
| Guangdong VTR Bio-Tech | 2.99B |
| Suzhou Fushilai Pharmaceutical | 2.87B |
| Shanghai Hile Bio-Technology | 2.81B |
| Shandong Sito Bio-technology | 2.65B |
| Hubei Goto Biopharm | 2.50B |
| Jilin Jian Yisheng Pharmaceutical | 2.49B |
| Sailong Pharmaceutical Group | 2.32B |